Cargando…
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
BACKGROUND: The role of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) induction coupled with standard concurrent chemoradiotherapy (CRT) is unclear in unresectable, stage III, EGFR-mutant non-small-cell lung cancer (NSCLC). Therefore, a phase II trial was conducted to evalu...
Autores principales: | Hotta, K., Saeki, S., Yamaguchi, M., Harada, D., Bessho, A., Tanaka, K., Inoue, K., Gemba, K., Shiojiri, M., Kato, Y., Ninomiya, T., Kubo, T., Kishimoto, J., Shioyama, Y., Katsui, K., Sasaki, J., Kiura, K., Sugio, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233144/ https://www.ncbi.nlm.nih.gov/pubmed/34153652 http://dx.doi.org/10.1016/j.esmoop.2021.100191 |
Ejemplares similares
-
Dissemination of Cost Action FP0905 information by website
por: Migliacci, Fabio, et al.
Publicado: (2011) -
Digitale Logik
por: Stuckenberg, Hans Joachim
Publicado: (1970) -
Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
por: Sato, Hiroki, et al.
Publicado: (2018) -
Wissenschaft der Logik
por: Hegel, Georg Wilhelm Friedrich, 1770-1831
Publicado: (1948) -
Grundzüge der theoretischen Logik
por: Hilbert, David, et al.
Publicado: (1959)